{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:17:18Z","timestamp":1760015838523,"version":"3.37.3"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["RO1 CK 000152"],"award-info":[{"award-number":["RO1 CK 000152"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.diagmicrobio.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T22:16:54Z","timestamp":1547158614000},"page":"192-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of a 14-day course of amoxicillin for patients with erythema migrans"],"prefix":"10.1016","volume":"94","author":[{"given":"Gary P.","family":"Wormser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn C.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Scavarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0010","first-page":"299","article-title":"Idiosyncratic drug-induced neutropenia and agranulocytosis","volume":"110","author":"Andres","year":"2017","journal-title":"QJM"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/INF.0000000000000804","article-title":"Azithromycin is equally effective as amoxicillin in children with solitary erythema migrans","volume":"34","author":"Arnez","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/02813432.2017.1288812","article-title":"Symptom load and general function among patients with erythema migrans: a prospective study with a one year follow-up after antibiotic treatment in Norwegian general practice","volume":"35","author":"Eliassen","year":"2017","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.02.028","article-title":"Comparison of phenoxymethyl penicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a one year follow-up","author":"Eliassen","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0035","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/AAC.40.5.1104","article-title":"Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis","volume":"40","author":"Karlsson","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijantimicag.2007.11.011","article-title":"Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials","volume":"31","author":"Lee","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","article-title":"The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans","volume":"100","author":"Nadelman","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0055","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00508-012-0194-1","article-title":"Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin","volume":"124","author":"Nizic","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","article-title":"Long-term follow-up of patients with culture-confirmed Lyme disease","volume":"115","author":"Nowakowski","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0070","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0075","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/JCM.30.12.3082-3088.1992","article-title":"Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions","volume":"30","author":"Schwartz","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0085","first-page":"2237","article-title":"Antibiotic-associated neutropenia","volume":"45","author":"Walbroehl","year":"1992","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0090","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0095","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2019.01.003_bb0100","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/314053","article-title":"Practice guidelines for the treatment of Lyme disease","volume":"31","author":"Wormser","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/JCM.36.1.296-298.1998","article-title":"Improving the yield of blood cultures for patients with early Lyme disease","volume":"36","author":"Wormser","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.01.003_bb0110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease: a randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318303304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318303304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T07:15:41Z","timestamp":1606029341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318303304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0732889318303304"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.01.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a 14-day course of amoxicillin for patients with erythema migrans","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}